(Reuters) - The U.S. Food and Drug Administration on Tuesday said it was investigating deaths of two patients who died following injections with Eli Lilly and Co's long-acting treatment for schizophrenia, called Zyprexa Relprevv. Full story
(Reuters) - The U.S. Food and Drug Administration on Tuesday said it was investigating the deaths of two patients who died following injections with Eli Lilly and Co's long-acting treatment for schizophrenia, called Zyprexa Relprevv. Full story
NEW YORK (Reuters) - The U.S. Food and Drug Administration on Wednesday won a temporary halt to part of a court order directing it to make emergency contraception available to girls over the counter. Full story
(Reuters) - Canada drugmaker Valeant Pharmaceuticals International said on Tuesday that the U.S. Food and Drug Administration denied approval for its drug to treat onychomycosis, a fungal infection of the nail. Full story
(Reuters) - AcelRX Pharmaceuticals Inc said its experimental treatment for post-operative pain met its main goal in a late-stage trial of patients who had undergone knee or hip replacement surgery, sending its shares up 15 percent. Full story
(Reuters) - Aveo Pharmaceuticals Inc and Astellas Pharma Inc have not demonstrated that the benefits of their experimental kidney cancer drug tivozanib outweighs the risk, an advisory panel to the U.S. Food and Drug Administration said on Thursday. Full story
A Plan B One-Step emergency contraceptive box is seen in New York, April 5, 2013. A federal judge on Friday ordered the U.S. Food and Drug Administration to make "morning-after" emergency contraception pills available without a prescription to all girls of reproductive age. REUTERS/Shannon Stapleton
The headquarters of the U.S. Food and Drug Administration is shown in Silver Spring, Maryland, November 4, 2009. REUTERS/Jason Reed
Staff Scientist Ji Guo inspects test tubes containing dyes in a laboratory at the U.S. Food and Drug Administration in Silver Spring, Maryland in this file photo from August 14, 2012. Picture taken August 14, 2012. The Food and Drug Administration announced a reduction of $133 million in non-user
Staff Scientist Ji Guo inspects test tubes containing dyes in a laboratory at the U.S. Food and Drug Administration in Silver Spring, Maryland in this August 14, 2012 file photo. Research and the fight against infectious diseases could be on the list of cutbacks as the White House warns of possibl
